Name: Altraz
SKU: 24094
Availability: InStock

📋 Product Overview Table

🌐 Specification	🧾 Details
💊 Active Ingredient	Anastrozole 1mg
🧪 Formulation	Aromatase Inhibitor Tablet
🏭 Manufacturer	Alkem Laboratories Ltd
💊 Dosage Form	Oral Tablet
📦 Packaging	14 Tablets in 1 Strip
🩺 Indication	Hormone receptor-positive breast cancer in postmenopausal women
🇺🇸 US Brand Equivalent	Arimidex (by AstraZeneca)
⏱️ Delivery Time	6 to 15 days

🧬 Introduction – What is Altraz (Anastrozole) 1mg?

Altraz is a potent aromatase inhibitor manufactured by Alkem Laboratories Ltd, designed to treat hormone receptor-positive breast cancer in postmenopausal women. It contains Anastrozole 1mg, the same active ingredient found in the globally known brand Arimidex.

Anastrozole works by blocking the enzyme aromatase, which is responsible for the conversion of androgens to estrogen. Since certain breast cancers grow in response to estrogen, Altraz effectively reduces estrogen levels, helping prevent cancer recurrence and progression.

It is often used as a first-line treatment or as adjuvant therapy after surgery, chemotherapy, or radiation.

🎥 Video Overview – Understanding Aromatase Inhibitors

📺 “How Altraz (Anastrozole) Works Against Hormone-Sensitive Breast Cancer“

🎬 Video Placeholder – Features a breakdown of aromatase inhibition and its role in cancer management.

Always consult an oncologist before starting hormone therapy. Altraz is for prescription use only.

🔬 Pharmacological Profile

🧪 Property	📊 Details
Drug Class	Non-steroidal Aromatase Inhibitor
Bioavailability	Approximately 83–85% (oral)
Elimination Half-Life	~50 hours
Metabolism	Hepatic (CYP3A4, CYP2C8 pathways)
Excretion	Renal and fecal

💡 Dosing Instructions

🗓️ Schedule	💊 Dosage
Standard Adult Dose	1 tablet (1mg) once daily
With/Without Food	Can be taken with or without meals
Duration of Treatment	Typically 5 years or as prescribed

Dosage and duration may vary depending on cancer stage and therapy response.

⚠️ Side Effects & Warnings

💥 Common Side Effects	❗ Severe Adverse Effects (Rare)
Hot flashes, joint pain	Osteoporosis, bone fractures
Weakness, nausea	Liver enzyme abnormalities
Mood changes, vaginal dryness	Cardiovascular events (in high-risk patients)

Contraindications: Premenopausal women, pregnancy, severe hepatic impairment.

🧃 Storage Instructions

Store below 25°C
Protect from moisture and direct sunlight
Keep out of reach of children

🌍 Global Availability & Import Notes

🌎 Country	📦 Import Policy	📋 Prescription Required
🇺🇸 USA	Allowed via personal importation policy	Yes
🇬🇧 UK	MHRA allows import for personal use	Yes
🇦🇺 Australia	TGA permits import with valid prescription	Yes

🔗 Related Products (Internal Links)

💊 Product Name	🏭 Manufacturer	📖 Description
Fempro 2.5mg	Cipla Ltd	Letrozole-based aromatase inhibitor used for breast cancer treatment
Letoval 2.5mg	Sun Pharma	Letrozole tablet for hormone-sensitive cancers
Tamoxifen 20mg	Kachhela Medex	Estrogen receptor modulator for pre- and postmenopausal breast cancer
Arimee 1mg	Healing Pharma	Anastrozole generic with identical therapeutic action
Exemestane 25mg	Natco Pharma	Steroidal aromatase inhibitor alternative

📚 References & External Resources

🩺 Expert Commentary – Dr. Renu Sinha, MD (Oncology)

“Altraz offers a cost-effective and clinically proven option for postmenopausal women with hormone-sensitive breast cancer. Its high bioavailability and tolerable side effect profile make it suitable for long-term adjuvant therapy.”

⚠️ Disclaimer

This content is for informational purposes only and not a substitute for medical advice. Always consult an oncologist before starting treatment with Altraz or any hormonal therapy.